No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ZNTL240719P2500
- 0.05
- 0.000.00%
15min DelayClose Jul 1 09:45 ET
0.00High0.00Low
0.05Open0.05Pre Close0 Volume102 Open Interest2.50Strike Price0.00Turnover171.84%IV41.53%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier18DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0614Delta0.0754Gamma83.80Leverage Ratio-0.0053Theta-0.0001Rho-5.14Eff Leverage0.0011Vega
Intraday
- 5D
- Daily
News
Express News | Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
(ZNTL) - Analyzing Zentalis Pharma's Short Interest
12 Health Care Stocks Moving In Thursday's Intraday Session
Express News | Zentalis Pharmaceuticals Shares Are Trading Higher After Falling on Tuesday Following a Hold Partial Clinical Hold on Partial Clinical Hold on
Express News | Zentalis Pharmaceuticals Shares up About 32%
Express News | Zentalis Pharmaceuticals Inc : UBS Cuts to Neutral From Buy
Comments
Wall Street experts reveal the five stocks to buy, five stocks to sell this week
What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street's best analysts during the week of June 17-21.
Top 5 Buy Calls:
1. Skyworks upgraded to Buy at B. Riley
$Skyworks Solutions(SWKS.US$
B. Riley upgraded Skyworks (SWKS) to Buy from Neutral with a price target of $130, up from $96, ahead of the July 8 through 11 SEM...
What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street's best analysts during the week of June 17-21.
Top 5 Buy Calls:
1. Skyworks upgraded to Buy at B. Riley
$Skyworks Solutions(SWKS.US$
B. Riley upgraded Skyworks (SWKS) to Buy from Neutral with a price target of $130, up from $96, ahead of the July 8 through 11 SEM...
1
The satisfactory 2.7 years cash runway is overshadowed by increased cash burn rate of 19%. The firm's potential to raise funds for growth via new shares may entail dilution of existing ones. Close monitoring of Zentalis Pharmaceuticals' cash burn situation advised.
Gainers:
• $Enphase Energy(ENPH.US$ +8.2% (earnings reports)
• $Zentalis Pharmaceuticals(ZNTL.US$ +7.6% (announces $25 mln equity investment from Pfizer (PFE); enters into development collaboration for ZN-c3)
• $Ternium(TX.US$ +6.1% (earnings reports)
• $PureCycle Technologies(PCT.US$ +5% (SEC concludes investigation without further action)
• $Alliance Resource(ARLP.US$ +4.7% (increases dividend; provides prelim qtrly results)
• $Digital World Acquisition Corp(DWAC.US$ +4.5% (cu...
• $Enphase Energy(ENPH.US$ +8.2% (earnings reports)
• $Zentalis Pharmaceuticals(ZNTL.US$ +7.6% (announces $25 mln equity investment from Pfizer (PFE); enters into development collaboration for ZN-c3)
• $Ternium(TX.US$ +6.1% (earnings reports)
• $PureCycle Technologies(PCT.US$ +5% (SEC concludes investigation without further action)
• $Alliance Resource(ARLP.US$ +4.7% (increases dividend; provides prelim qtrly results)
• $Digital World Acquisition Corp(DWAC.US$ +4.5% (cu...
14
1
Upgrades
• $Banc of California(BANC.US$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $Cullen/Frost Bankers(CFR.US$: Raymond James Upgrades to Outperform from Market Perform
• $W.W. Grainger(GWW.US$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes Inc(INVH.US$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp(PCB.US$: Raymond James Upgrades to Outperform from Market Perfor...
• $Banc of California(BANC.US$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $Cullen/Frost Bankers(CFR.US$: Raymond James Upgrades to Outperform from Market Perform
• $W.W. Grainger(GWW.US$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes Inc(INVH.US$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp(PCB.US$: Raymond James Upgrades to Outperform from Market Perfor...
7
Read more